Key result
Coronary artery calcium screening improves coronary heart disease risk stratification in patients with metabolic syndrome and diabetes mellitus.
Why the study?
Does coronary artery calcium screening improve CHD risk assessment in persons with metabolic syndrome and diabetes mellitus?
Does coronary artery calcium screening improve CHD risk assessment in persons with metabolic syndrome and diabetes mellitus?
CAC screening provides added utility for CHD risk stratification in patients with metabolic syndrome and diabetes mellitus, helping to identify those who may benefit from more intensive preventive therapy.
No takes yet. Share an insight, caveat, or question.
May support CAC for CHD risk stratification in metabolic syndrome and diabetes; leaves open need for prospective outcome trials.
Tehrani et al. (2013) conducted a review in Metabolic syndrome and diabetes mellitus. Coronary artery calcium (CAC) screening was evaluated on Coronary heart disease (CHD) risk. Coronary artery calcium screening improves coronary heart disease risk stratification in patients with metabolic syndrome and diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: